Miller Richard A Md - SEC Form 4 Insider Trading Screener
CIK: 1031847 - Address: Corvus Pharmaceuticals, Inc., 863 Mitten Road, Suite 102, Burlingame, CA 94010
5 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-12-06 | CRVS | Miller Richard A Md | Pres, CEO | P - Purchase | $5.99 | +5,000 | 1,118,795 | 0% | +$29,934 | ||||||
2018-12-04 | CRVS | Miller Richard A Md | Pres, CEO | P - Purchase | $5.95 | +1,502 | 1,113,795 | 0% | +$8,937 | ||||||
2018-03-12 | CRVS | Miller Richard A Md | Pres, CEO | P - Purchase | $8.50 | +100,000 | 1,112,293 | +10% | +$850,000 | ||||||
2017-11-20 | CRVS | Miller Richard A Md | Pres, CEO | P - Purchase | $10.79 | +10,000 | 1,012,293 | +1% | +$107,850 | ||||||
| M | 2017-06-09 | CRVS | Miller Richard A Md | Pres, CEO | P - Purchase | $9.88 | +25,000 | 1,002,293 | +3% | +$247,084 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |